A Phase II Efficacy Study of Intracerebral CTX0E03 DP in Patients With Stable Paresis of the Arm Following an Ischaemic Stroke.

Trial Profile

A Phase II Efficacy Study of Intracerebral CTX0E03 DP in Patients With Stable Paresis of the Arm Following an Ischaemic Stroke.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2017

At a glance

  • Drugs ReN 001 (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms PISCES II
  • Sponsors ReNeuron
  • Most Recent Events

    • 01 Dec 2017 Status changed from active, no longer recruiting to completed.
    • 31 Oct 2017 12 months post-treatment data from this trial will be presented at an upcoming medical conference, according to a ReNeuron media release.
    • 31 Oct 2017 Results after 12 months treatment published in the ReNeuron media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top